Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL28029697 | 0.98 | FFAR3 (0.33) | FFAR3CYP1A2 | |
| SCHEMBL7327673 | 0.78 | FFAR3 (0.36) | FFAR3CYP1A2 | |
| SCHEMBL9342145 | 0.74 | FFAR3 (0.30) | FFAR3 | |
| SCHEMBL10438922 | 0.69 | PTGS1 (0.30) | — | |
| SCHEMBL15845002 | 0.67 | GRIK1 (0.32) | — | |
| SCHEMBL10766355 | 0.66 | PTPN2 (0.39) | CYP1A2 | |
| SCHEMBL21457841 | 0.65 | GRIK1 (0.33) | CYP1A2 | |
| SCHEMBL10937386 | 0.65 | CYP1A2 (0.30) | CYP1A2 | |
| SCHEMBL10937376 | 0.65 | CYP1A2 (0.30) | CYP1A2 | |
| SCHEMBL15827327 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2024-02-15 | — | — | US | claimed |
| US-20230060897-A1 | COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF RAW MATERIAL MALODOURS IN SOAP BASES | FIRMENICH SA (CH) | 2023-03-02 | — | — | US | claimed |
| US-20220364016-A1 | PERFUME OIL MIXTURE | SYMRISE AG (DE) | 2022-11-17 | — | — | US | claimed |
| CN-114599771-A | Composition for limiting or eliminating perception of off-flavor in raw materials in soap base | 弗门尼舍有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-114096235-A | Antimicrobial compositions | 弗门尼舍有限公司 | 2022-02-25 | — | — | CN | claimed |
| EP-2059265-B1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | FIRMENICH & CIE (CH) | 2018-10-17 | — | — | EP | claimed |
| EP-3197507-A1 | MALODOR REDUCTION COMPOSITIONS | The Procter and Gamble Company (US) | 2017-08-02 | — | — | EP | claimed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20130164239-A1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | FIRMENICH SA (CH) | 2013-06-27 | — | — | US | claimed |
| US-20100028288-A1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | FIRMENICH SA (CH) | 2010-02-04 | — | — | US | claimed |
| EP-2059265-A2 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | Firmenich S.A. (CH) | 2009-05-20 | — | — | EP | claimed |
| WO-2008026140-A2 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | FIRMENICH SA (CH) | 2008-03-06 | — | — | WO | claimed |
| EP-1682230-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | Symrise GmbH & Co. KG (DE) | 2006-07-26 | — | — | EP | claimed |
| WO-2005004825-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | claimed |
| EP-0378825-B1 | Alicyclic esters and their use as flavouring agents | FIRMENICH & CIE (CH) | 1994-07-06 | — | — | EP | claimed |
| US-12421474-B2 | Perfume oil mixture | SYMRISE AG (DE) | 2025-09-23 | — | — | US | disclosed |
| WO-2008026140-A2 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | FIRMENICH SA (CH) | 2008-03-06 | — | — | WO | disclosed |
| US-20060207037-A1 | Malodor covering perfumery | GIVAUDAN FRAGRANCES CORPORATION | 2006-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130164239-A1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | NOX5, CUTA, SMURF1 | FFAR3 793/4885CYP1A2 523/4885 |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | OR10J3, OR51E2, MAL2 | FFAR3 2016/4885CYP1A2 90/4885 |
| US-20100028288-A1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | MYOC, AOC1, CUTA | FFAR3 1201/4885CYP1A2 776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.